Presenter's Information
Tullio Palmerini, MD
Country | Italy |
Specialty | Interventional Cardiologist |
- Escalation Strategy of Antithrombotic Therapy: Why, in Whom, and How?
- When to Escalate or De-Escalate in ACS/PCI
- Coronary Protection in Patients Undergoing TAVR at High Risk of Coronary Occlusion
- Coronary Protection in Patients Undergoing TAVI at High Risk of Coronary Occlusion
- Next Innovation in Transcatheter Valve Intervention: New Techniques and New Valves
- Modulation of DAPT Duration: Risk-benefit of 1-year DAPT
- Inteventionist's Perspective
- Practical Considerations for Long DAPT Based on Lesion and Patient Selections
- Different Drug, Polymer, and Platform and So Many Stents - Are There Meaningful Differences?
- How Much Can We Trust Meta-Analysis: The Good, the Bad, and the Ugly
- Updated RCT Long-term Data and Meta-analyses for LM Revascularization
- Is In-Stent Restenosis a Benign Event?
- DAPT Dilemmas in ACS: Where to Go - Shorter vs. Longer Durations?
- Updated Meta-Analysis of Bioresorbable Scaffolds: Sum Up Many, Many Meta for BRS
- Updated Meta-Analysis for PCI vs. CABG for Left Main Disease
- Ischemic and Bleeding Risk Prediction: Many Scores, Little Solutions
- All Contemporary DES Comparison; Worldwide Clinical Trial Summary
- New Meta-Analysis of RCTs in LM Revascularization
- Is Mortality a Concern After Prolonged DAPT After DES Implantation?
- Pre and Post EXCEL and NOBLE Era; What Will Change in LM Treatment?